EC
EVH icon

Elequin Capital’s Evolent Health EVH Stock Holding History

Elequin Capital’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$32 Sell
14
-46
-77% -$146 ﹤0.01% 619
2025
Q4 		$240 Buy
+60
New +$334 ﹤0.01% 395
2025
Q1 		– Sell
-152
Closed -$1.71K – 419
2024
Q4 		$1.71K Sell
152
-236
-61% -$4.15K ﹤0.01% 450
2024
Q3 		$11K Buy
+388
New +$10K ﹤0.01% 229

Other funds holding EVH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Elequin Capital's EVH Position: Q1 2026 in Review

Elequin Capital reduced its Evolent Health (EVH) stake by 77% in Q1 2026, selling an estimated $146 and leaving 14 shares worth $32. The position accounts for ﹤0.01% of the portfolio, ranked #619.

Elequin Capital first reported a position in EVH in Q3 2024 and has held it in 4 quarters since. The position peaked at $11K in Q3 2024. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

  • Elequin Capital held 14 shares of Evolent Health worth $32 as of Q1 2026.
  • Elequin Capital sold 46 Evolent Health shares in Q1 2026, an estimated $146.
  • Evolent Health made up ﹤0.01% of Elequin Capital's portfolio in Q1 2026, its #619 holding.
  • Elequin Capital first reported a position in Evolent Health in Q3 2024 and has held it in 4 quarters since.
  • Elequin Capital's Evolent Health position peaked at $11K in Q3 2024.
  • 191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on Elequin Capital's 13F filing for Q1 2026, filed 11 May 2026.